Home

Martine A. Rothblatt, Chairperson & CEO: United Therapeutics UTHR Sell · Filed 05/26

Trade details

Type
Insider sale
Amount
$2,503,176
Shares · price
4,407 sh · $568.00 a share
Held after
41,854 sh
Trade date
26/05/22
Filed
26/05/26
Days to filing
4 days

Sold 9.5% of holdings

Share of holding sold
9.5%

United Therapeutics trades, last 26 weeks

What else happened in United Therapeutics around then

Filed or reported within 30 days of the trade day · 04/22~06/21

Martine A. Rothblatt's recent trades

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $220.2K

    Filed 10/01

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $218.9K

    Filed 10/01

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $153.5K

    Filed 10/01

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $131.9K

    Filed 10/01

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $114.8K

    Filed 10/01

Martine A. Rothblatt, Chairman — sold $2.5M of United Therapeutics UTHR · 9.5% of holdings · 10b5-1 plan | Whalegun